Hungary - Marriot Hotel, Budapest
The International Scientific Symposium on Bacteriocins and Antimicrobial Peptides –BAMP will be highlight subject at this year’s International Probiotic Conference on Probiotics and Prebiotics – IPC 2016.
The selection of the subject fields has been based on the feedback of former IPC participants. Symposium will serve as scientific forum where academic and industrial scientists involved in the respective research area meet. Further to its scientific content the symposium is networking event. Abstracts of oral presentations and posters will be published in the official proceedings of the IPC 2016.
Date: 22nd June 2016
Place: Marriott hotel Budapest
The Bacteriocins Symposium will be part of the conference programme, under the chairmanship of Svetoslav Todorov, Veterinary Department, Universidade Federal de Viçosa, Minas Gerais, Brazil.
The programme of the Scientific Symposium on Bacteriocins will focus on the developments in the science, research and application of bacteriocins.
Current advances in isolation, characterization and application of bacteriocins will be presented. Internationally renowned experts from industry and academia will discuss the mechanisms of action and the role of bacteriocins in food safety.
It is the goal of the symposium to further explore the potential of already known and novel bacteriocins by disseminating latest results and presenting new ways of bacteriocin research. The horizon of the application of bacteriocins have been enlarged and based on intensive research worldwide, novels applications of bacteriocins have been addressed.
From the discovery of nisin produced by Lactococcus lactis in 1933, more than 7,000 papers published in different scientific journal around the world until 2015: this is a short story of the bacteriocins. From the application in the biopreservation in the control of spoilage organisms, prevention of the foodborne pathogens to the innovative application in the control of human and other animals’ diseases, this is the future of these antimicrobial peptides. Described as antimicrobial agents, active against closely related microorganisms, nowadays we have knowledge on the inhibitory effect and potential application of bacteriocins against some Gram-negative microorganisms, viruses, Mycobacterium spp., fungus, etc.
However, what about application of bacteriocins as an alternative or synergetic compound/s in human and veterinary medicine? Is this will be an answer/solution in increased problem with antibiotic resistance? New horizons in the application of bacteriocins were reached and the life story of these antimicrobial peptides is just begun.